Predictions of the maximum number of confirmed cases and deaths of COVID-19 in Brazil
Autor(a) principal: | |
---|---|
Data de Publicação: | 2021 |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Vigilância Sanitária em Debate |
Texto Completo: | https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1774 |
Resumo: | Introduction: COVID-19 started in December 2019 in China and in February 2020 in Brazil. As of August 29, 2020, Brazil had 3,717,156 confirmed cases (60.6% of the total in America and 15.0% of the total World) and 117,665 deaths (59.4% of the total in America and 14.0% of the World total), the second place in the world. Objective: To estimate maximum limits for the quantitative number of confirmed cases and deaths of COVID-19 in Brazil. Method: The maximum estimates of confirmed cases and deaths were estimated by applying nonlinear regression with adjustment of the Gompertz function to the COVID-19 data recorded until the end of August 2020. Results: As results were obtained a maximum of 7,189,300 confirmed cases, with 95.0% of the maximum reached in February 2021 and 164,810 deaths, with 95.0% of the maximum reached in December 2020. Conclusions: These forecasts express the trend of temporal evolution of COVID-19 reported data by Our World in Data. They do not consider underreporting in the number of contaminated people and deaths, taking into account the limited testing capacity of the population and the existence of unaccounted asymptomatic contaminated people. These factors added to the uncontrolled relaxation of individual preventive measures and social distancing may have a significant effect on the predictions of the mathematical model used in this work and on the understanding of the transmission of the virus in Brazil. |
id |
FIOCRUZ-9_3b67f2a5ad954af167e14f1e8e1f1e4f |
---|---|
oai_identifier_str |
oai:ojs.visaemdebate.incqs.fiocruz.br:article/1774 |
network_acronym_str |
FIOCRUZ-9 |
network_name_str |
Vigilância Sanitária em Debate |
repository_id_str |
|
spelling |
Predictions of the maximum number of confirmed cases and deaths of COVID-19 in BrazilPrevisões de máximo de casos confirmados e óbitos de COVID-19 no BrasilPrevisão; Coronavírus; COVID-19; GompertzPrediction; Coronavirus; Covid-19; GompertzIntroduction: COVID-19 started in December 2019 in China and in February 2020 in Brazil. As of August 29, 2020, Brazil had 3,717,156 confirmed cases (60.6% of the total in America and 15.0% of the total World) and 117,665 deaths (59.4% of the total in America and 14.0% of the World total), the second place in the world. Objective: To estimate maximum limits for the quantitative number of confirmed cases and deaths of COVID-19 in Brazil. Method: The maximum estimates of confirmed cases and deaths were estimated by applying nonlinear regression with adjustment of the Gompertz function to the COVID-19 data recorded until the end of August 2020. Results: As results were obtained a maximum of 7,189,300 confirmed cases, with 95.0% of the maximum reached in February 2021 and 164,810 deaths, with 95.0% of the maximum reached in December 2020. Conclusions: These forecasts express the trend of temporal evolution of COVID-19 reported data by Our World in Data. They do not consider underreporting in the number of contaminated people and deaths, taking into account the limited testing capacity of the population and the existence of unaccounted asymptomatic contaminated people. These factors added to the uncontrolled relaxation of individual preventive measures and social distancing may have a significant effect on the predictions of the mathematical model used in this work and on the understanding of the transmission of the virus in Brazil.COVID-19 comenzó en diciembre de 2019 en China y febrero de 2020 en Brasil. Al 29 de agosto de 2020, Brasil tenía 3.717.156 casos confirmados (60,6% del total en América y 15% del mundo total) y 117.665 (59,4% del total en América y 14% del mundo total) el segundo lugar en el mundo. En este estudio, el número máximo de casos confirmados y muertes se estimó utilizando el método de regresión no lineal con el ajuste de la función Gompertz a los datos COVID-19 registrados a finales de agosto de 2020. Como resultado, se obtuvieron un máximo de 7.189.300 casos confirmados, con el 95% del máximo alcanzado en febrero de 2021 y 164.810 muertes, con el 95% del máximo alcanzado en diciembre de 2020. Estas predicciones expresan la tendencia matemática de la evolución temporal de los datos ya registrados y los valores reales de la pandemia COVID-19 en Brasil dependerán del desarrollo de la transmisión del virus frente al cuidado personal y el distanciamiento social, así como de la capacidad del sistema de salud para atender y probar casos sospechosos.Introdução: A COVID-19 teve início em dezembro de 2019 na China e em fevereiro de 2020 no Brasil. Até 29 de agosto de 2020, o Brasil possuía 3.717.156 casos confirmados (60,6% do total da América e 15,0% do total mundial) e 117.665 óbitos (59,4% do total da América e 14,0% do total mundial), ocupando o segundo lugar no mundo. Objetivo: Estimar limites máximos para os quantitativos de casos confirmados e óbitos por COVID-19 no Brasil. Método: A estimativa dos máximos de casos confirmados e óbitos foi realizada através da aplicação de regressão não linear com ajuste da função Gompertz aos dados de COVID-19 registrados até final de agosto de 2020. Resultados: Como resultados foram obtidos máximo de 7.189.300 casos confirmados, com 95,0% do máximo atingidos em fevereiro 2021 e 164.810 óbitos, com 95,0% do máximo atingidos em dezembro 2020. Conclusões: Essas previsões expressam a tendência da evolução temporal dos dados notificados de COVID-19 pelo Our World in Data. Eles não consideram a subnotificação no número de contaminados e de óbitos, tendo em conta a limitada capacidade de testagem da população e a existência de contaminados assintomáticos não contabilizados. Estes fatores somados ao relaxamento descontrolado das medidas preventivas individuais e do distanciamento social poderão ter um efeito significativos nas previsões do modelo matemático usado neste trabalho e no entendimento da transmissão do vírus no Brasil. Instituto Nacional de Controle de Qualidade em Saúde2021-02-26info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/177410.22239/2317-269x.01774Health Surveillance under Debate: Society, Science & Technology ; Vol. 9 No. 1 (2021): February; 12-17Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 9 Núm. 1 (2021): Febrero; 12-17Vigil Sanit Debate, Rio de Janeiro; v. 9 n. 1 (2021): Fevereiro; 12-172317-269Xreponame:Vigilância Sanitária em Debateinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporenghttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1774/1297https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1774/1345Copyright (c) 2021 Vigilância Sanitária em Debate: Sociedade, Ciência & Tecnologia (Health Surveillance under Debate: Society, Science & Technology) – Visa em Debatehttps://creativecommons.org/licenses/by-nc/4.0info:eu-repo/semantics/openAccessMaximiliano Dutra, Carlos 2023-06-27T16:48:59Zoai:ojs.visaemdebate.incqs.fiocruz.br:article/1774Revistahttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebatePUBhttps://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/oaiincqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br2317-269X2317-269Xopendoar:2023-06-27T16:48:59Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ)false |
dc.title.none.fl_str_mv |
Predictions of the maximum number of confirmed cases and deaths of COVID-19 in Brazil Previsões de máximo de casos confirmados e óbitos de COVID-19 no Brasil |
title |
Predictions of the maximum number of confirmed cases and deaths of COVID-19 in Brazil |
spellingShingle |
Predictions of the maximum number of confirmed cases and deaths of COVID-19 in Brazil Maximiliano Dutra, Carlos Previsão; Coronavírus; COVID-19; Gompertz Prediction; Coronavirus; Covid-19; Gompertz |
title_short |
Predictions of the maximum number of confirmed cases and deaths of COVID-19 in Brazil |
title_full |
Predictions of the maximum number of confirmed cases and deaths of COVID-19 in Brazil |
title_fullStr |
Predictions of the maximum number of confirmed cases and deaths of COVID-19 in Brazil |
title_full_unstemmed |
Predictions of the maximum number of confirmed cases and deaths of COVID-19 in Brazil |
title_sort |
Predictions of the maximum number of confirmed cases and deaths of COVID-19 in Brazil |
author |
Maximiliano Dutra, Carlos |
author_facet |
Maximiliano Dutra, Carlos |
author_role |
author |
dc.contributor.author.fl_str_mv |
Maximiliano Dutra, Carlos |
dc.subject.por.fl_str_mv |
Previsão; Coronavírus; COVID-19; Gompertz Prediction; Coronavirus; Covid-19; Gompertz |
topic |
Previsão; Coronavírus; COVID-19; Gompertz Prediction; Coronavirus; Covid-19; Gompertz |
description |
Introduction: COVID-19 started in December 2019 in China and in February 2020 in Brazil. As of August 29, 2020, Brazil had 3,717,156 confirmed cases (60.6% of the total in America and 15.0% of the total World) and 117,665 deaths (59.4% of the total in America and 14.0% of the World total), the second place in the world. Objective: To estimate maximum limits for the quantitative number of confirmed cases and deaths of COVID-19 in Brazil. Method: The maximum estimates of confirmed cases and deaths were estimated by applying nonlinear regression with adjustment of the Gompertz function to the COVID-19 data recorded until the end of August 2020. Results: As results were obtained a maximum of 7,189,300 confirmed cases, with 95.0% of the maximum reached in February 2021 and 164,810 deaths, with 95.0% of the maximum reached in December 2020. Conclusions: These forecasts express the trend of temporal evolution of COVID-19 reported data by Our World in Data. They do not consider underreporting in the number of contaminated people and deaths, taking into account the limited testing capacity of the population and the existence of unaccounted asymptomatic contaminated people. These factors added to the uncontrolled relaxation of individual preventive measures and social distancing may have a significant effect on the predictions of the mathematical model used in this work and on the understanding of the transmission of the virus in Brazil. |
publishDate |
2021 |
dc.date.none.fl_str_mv |
2021-02-26 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1774 10.22239/2317-269x.01774 |
url |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1774 |
identifier_str_mv |
10.22239/2317-269x.01774 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1774/1297 https://visaemdebate.incqs.fiocruz.br/index.php/visaemdebate/article/view/1774/1345 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by-nc/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
publisher.none.fl_str_mv |
Instituto Nacional de Controle de Qualidade em Saúde |
dc.source.none.fl_str_mv |
Health Surveillance under Debate: Society, Science & Technology ; Vol. 9 No. 1 (2021): February; 12-17 Vigilancia en Salud en Debate: Sociedad, Ciencia y Tecnología; Vol. 9 Núm. 1 (2021): Febrero; 12-17 Vigil Sanit Debate, Rio de Janeiro; v. 9 n. 1 (2021): Fevereiro; 12-17 2317-269X reponame:Vigilância Sanitária em Debate instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ |
instname_str |
Fundação Oswaldo Cruz (FIOCRUZ) |
instacron_str |
FIOCRUZ |
institution |
FIOCRUZ |
reponame_str |
Vigilância Sanitária em Debate |
collection |
Vigilância Sanitária em Debate |
repository.name.fl_str_mv |
Vigilância Sanitária em Debate - Fundação Oswaldo Cruz (FIOCRUZ) |
repository.mail.fl_str_mv |
incqs.visaemdebate@fiocruz.br || gisele.neves@fiocruz.br |
_version_ |
1797042046483038208 |